DLHCX
Price
$20.90
Change
-$0.03 (-0.14%)
Updated
Jul 25 closing price
Net Assets
647.12M
JFNIX
Price
$67.37
Change
+$0.24 (+0.36%)
Updated
Jul 25 closing price
Net Assets
4.4B
Interact to see
Advertisement

DLHCX vs JFNIX

Header iconDLHCX vs JFNIX Comparison
Open Charts DLHCX vs JFNIXBanner chart's image
Macquarie Healthcare C
Price$20.90
Change-$0.03 (-0.14%)
VolumeN/A
Net Assets647.12M
Janus Henderson Global Life Sciences I
Price$67.37
Change+$0.24 (+0.36%)
VolumeN/A
Net Assets4.4B
DLHCX vs JFNIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLHCX vs. JFNIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.4B vs. DLHCX (647M). JFNIX pays higher dividends than DLHCX: JFNIX (0.41) vs DLHCX (0.00). DLHCX was incepted earlier than JFNIX: DLHCX (16 years) vs JFNIX (16 years). DLHCX (2.00) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. DLHCX (5.00). DLHCX has a lower initial minimum investment than JFNIX: DLHCX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -14.09 vs. DLHCX (-19.49). JFNIX return over 5 years is better than : 5.60 vs. DLHCX (-19.12).
DLHCXJFNIXDLHCX / JFNIX
Total Expense Ratio1.960.77255%
Annual Report Gross Expense Ratio2.000.77260%
Fund Existence16 years16 years-
Gain YTD-0.381-0.95640%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets647M4.4B15%
Annual Yield % from dividends0.000.41-
Returns for 1 year-19.49-14.09138%
Returns for 3 years-12.959.36-138%
Returns for 5 years-19.125.60-341%
Returns for 10 years1.657.7921%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMIDX18.310.19
+1.05%
Brown Advisory Mid-Cap Growth Investor
TRSZX22.830.19
+0.84%
T. Rowe Price Mid-Cap Index Z
MSFLX34.720.19
+0.55%
Morgan Stanley Inst Global Franchise L
JGTTX41.190.20
+0.49%
JPMorgan Growth Advantage R3
LMRNX33.170.10
+0.30%
1919 Socially Responsive Balanced I